Company
X4 Pharmaceuticals, Inc
XFOR · CIK 0001501697
Purchase of 4,600 shares at $2.5834 per share.
Reporting Person Craig Adam R · Officer Title Executive Chairman · Transaction Code P
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001339498-26-000005 · filed 2026-10-19 · View filing →
Sale of 11,767 shares at $2.8604 per share.
Reporting Person KIRSKE DAVID · Officer Title Chief Financial Officer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001501697-26-000078 · filed 2026-10-05 · View filing →
Sale of 47,436 shares at $4.4445 per share.
Reporting Person Craig Adam R · Officer Title Executive Chairman · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001501697-26-000069 · filed 2026-08-13 · View filing →
Sale of 24,576 shares at $4.4445 per share.
Reporting Person Volpone John · Officer Title President · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001501697-26-000070 · filed 2026-08-13 · View filing →